Giacomo is currently Head of Global Rare Diseases at the Chiesi Group, where he leads the team developing and commercializing treatments for rare and ultra-rare diseases.
He was previously Head of Global Corporate Development at the Chiesi Group where he led the team through more than 20 deals in just over two years.
The deals helped Chiesi enter and grow its presence in the US market, selectively expand in the over-the-counter space in Europe and establish a global portfolio and pipeline in rare diseases, which culminated in the constitution of a new business unit: Global Rare Diseases.
In his career, Giacomo has directly structured and executed deals with more than $3B in value ranging from sell-side to buy-side M&A, in- and out-licensing, and spin-outs.
In 2014, he founded Chiesi Ventures as a joint venture with Pappas Capital, where he currently serves as Managing Partner. He serves as a Board Member or Observer on the Boards of the Chiesi Group, Chiesi USA, Sentien Biotech and Minoryx Therapeutics. He previously was an observer or board member at Glycomine and Aura Biosciences.
Before joining the family business, Giacomo was a consultant with Bain & Co, where he led teams in a variety of assignments including due diligence, restructuring and strategy projects for consumer goods and IT companies in different countries. Previously he was with Accenture where he led large teams in outsourcing projects across Europe and US for clients in the transportation and retail business.
Giacomo earned a M.Sc. degree Magna cum Laude in Telecommunications Engineering from the University of Parma, Italy, and an MBA from the University of Chicago Booth School of Business with concentrations in Entrepreneurship and Finance. He goes to the gym every day and enjoys spending time with his wife and kids, reading, traveling, and playing his guitar.